PTGS2 and diabetes mellitus: Meanwhile, we revealed that COX-2 inhibitor celecoxib improves memory deficit and damage of hippocampal LTP in the diabetic model, indicating COX-2 is an essential therapeutic target for diabetes-associated memory and learning deficit.